vTv Therapeutics Inc.
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activa…
Biotechnology
US, High Point [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
vTv Therapeutics Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDvTv Therapeutics Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of vTv Therapeutics Inc..
If you want to see a demo, head over to the financial segments of AAPL